NEW YORK, July 14 /PRNewswire-FirstCall/ -- Derma Sciences, Inc.

PRINCETON, N.J., June 9 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, has been awarded the Healthcare Common Procedural Coding System (HCPCS) code A6266 for its BIOGUARD(TM) Conforming Bandage.

PRINCETON, N.J., June 7 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that its ALGICELL® Ag wound dressings have received a CE mark for use in the European Union.

PRINCETON, N.J., June 3 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that Edward J.

PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc.